OMRF has entered a license agreement with Shanghai RAAS Blood Products for development of novel hemophilia treatment.
Esmon
OMRF collaborates with GSK to develop novel treatments for severe inflammatory diseases
This collaboration is part of GSK’s “Discovery Partnerships with Academia” (DPAc) efforts.
Venture capital, biotech execs converge on OMRF
Networking, lab tours highlight first OMRF BioVenture Forum
OMRF researcher receives American Heart Association award
OMRF’s Charles Esmon was recognized by the AHA as a distinguished scientist.
OMRF shares in $23.8 million grant to research trauma
Trauma is a leading cause of death in people under age 34.
OMRF scientist takes aim at malaria
New research reveals a protein studied at OMRF plays a role in malarial stroke.
